coronavirus
classifi
genera
b
c
virus
detect
wide
rang
anim
speci
includ
human
previous
known
human
coronavirus
transmit
human
human
alphacoronavirus
betacoronavirus
common
respiratori
virus
usual
caus
mild
upper
respiratori
diseas
contrast
human
betacoronavirus
sar
mer
coronavirus
highli
pathogen
human
case
fatal
rate
sar
mer
respect
sar
mer
transmit
human
may
caus
major
outbreak
health
care
set
commun
set
sar
mer
coronavirus
zoonot
origin
mer
coronaviru
wide
circul
dromedari
camel
dromedari
camel
middl
east
countri
seroposit
mer
coronaviru
high
preval
anim
speci
sporad
zoonot
transmiss
mer
coronaviru
camel
human
repeatedli
detect
affect
region
sinc
discoveri
sar
outbreak
exot
mammal
wet
market
palm
civet
raccoon
dog
believ
anim
sourc
viru
detect
sar
coronaviru
speci
led
temporari
ban
sell
anim
therebi
prevent
addit
spillov
event
anim
human
surveil
studi
indic
anim
rare
posit
sar
coronaviru
nonmarket
set
suggest
serv
intermedi
host
sar
event
subsequ
viru
surveil
wild
anim
identifi
vast
number
coronavirus
bat
interestingli
sever
bat
coronavirus
genet
similar
human
sar
coronaviru
detect
horsesho
bat
group
sarslik
bat
coronavirus
togeth
sar
coronaviru
form
uniqu
clade
subgenu
sarbecoviru
gener
believ
sar
coronaviru
recombin
viru
sever
bat
sarslik
betacoronavirus
bat
coronavirus
experiment
capabl
infect
human
cell
cultur
suggest
anim
virus
recombin
pose
threat
human
health
decemb
cluster
atyp
pneumonia
patient
epidemiolog
link
wholesal
market
wuhan
detect
novel
betacoronaviru
name
coronaviru
identifi
patient
viru
genet
similar
bat
viru
subgenu
sarbecoviru
januari
case
includ
fatal
one
detect
wuhan
provinc
addit
confirm
patient
recent
travel
histori
wuhan
detect
multipl
countri
japan
south
korea
usa
thailand
confirm
case
epidemiolog
link
wet
market
suggest
possibl
humantohuman
transmiss
andor
multipl
spillov
event
differ
set
time
prepar
articl
hospit
outbreak
report
spectrum
diseas
human
yet
fulli
determin
sign
infect
highli
nonspecif
includ
respiratori
symptom
fever
cough
dyspnea
viral
pneumonia
thu
diagnost
test
specif
infect
urgent
need
confirm
suspect
case
screen
patient
conduct
viru
surveil
studi
report
develop
rtpcr
assay
detect
novel
viru
human
clinic
specimen
two
monoplex
realtim
rtpcr
assay
target
n
gene
region
design
base
first
publicli
avail
sequenc
genbank
access
number
download
sequenc
sar
coronaviru
bat
sarslik
coronavirus
repres
coronavirus
edit
align
phylogenet
analys
sequenc
perform
use
neighbor
join
method
mega
x
two
sequenc
region
n
highli
conserv
amongst
sarbecovirus
select
primer
probe
design
primer
probe
sequenc
gene
assay
forward
ct
r
ag
revers
r
ag
probe
format
w
wherea
primer
probe
sequenc
n
gene
assay
forward
revers
probe
format
expect
amplicon
size
n
gene
assay
bp
bp
respect
primer
probe
purchas
commerci
sourc
integr
dna
technolog
primer
probe
sequenc
subsequ
confirm
perfect
match
genom
sequenc
avail
global
initi
share
influenza
data
gisaid
http
wwwgisaidorg
access
number
epiisl
access
jan
typic
ml
monoplex
rtpcr
assay
contain
master
reaction
mixtur
taqman
fast
viru
master
mix
thermofish
mmoll
forward
primer
lmoll
revers
primer
lmol
probe
rna
sampl
rtpcr
reaction
conduct
thermal
cycler
realtim
pcr
system
thermofish
follow
condit
revers
transcript
c
min
inactiv
revers
transcriptas
c
cycl
pcr
amplif
denatur
c
annealingextend
c
time
rtpcr
run
h
min
viral
rna
purif
kit
qiaamp
viral
rna
mini
kit
qiagen
dna
plasmid
purif
kit
qiaprep
spin
miniprep
kit
qiagen
use
rna
dna
extract
respect
instruct
manufactur
rna
extract
rna
extract
ml
sampl
elut
ml
elut
buffer
contain
poli
carrier
rna
viral
rna
extract
sar
coronavirusinfect
cell
use
posit
control
addit
rtpcr
product
sar
coronaviru
gener
n
gene
assay
clone
plasmid
serial
dilut
rna
dna
sampl
use
evalu
perform
assay
determin
specif
assay
neg
control
sampl
test
neg
control
sampl
rna
extract
cultur
virus
human
coronavirus
mer
camel
coronaviru
human
influenza
virus
subtyp
avian
influenza
subtyp
influenza
b
virus
yamagata
victoria
lineag
adenoviru
rna
extract
retrospect
human
respiratori
specimen
previous
test
posit
coronaviru
influenza
virus
subtyp
influenza
b
virus
yamagata
victoria
lineag
adenoviru
enteroviru
human
parainfluenza
viru
respiratori
syncyti
viru
human
metapneumoviru
rhinoviru
human
bocaviru
rna
extract
sputum
sampl
patient
without
respiratori
viral
infect
n
cultur
supernat
infect
cell
clinic
sampl
store
standard
viru
transport
media
subject
brief
centrifug
g
min
ml
supernat
sampl
use
rna
extract
two
patient
patient
suspect
infect
beij
includ
studi
patient
sputum
sampl
collect
day
postonset
symptom
sputum
sampl
store
standard
viru
transport
media
treat
equal
volum
sputasol
thermofish
rna
extract
patient
throat
swab
sampl
collect
day
postonset
symptom
store
standard
viru
transport
media
ml
aqueou
sampl
use
viral
rna
extract
relev
clinic
epidemiolog
data
patient
access
studi
rna
extract
sampl
serial
dilut
test
assay
time
prepar
assay
one
viral
sequenc
avail
public
domain
limit
sequenc
inform
decid
develop
two
rtpcr
assay
react
multipl
coronavirus
subgenu
sarbecoviru
fig
see
discuss
use
addit
sequenc
inform
clade
coronavirus
select
highli
conserv
n
gene
region
target
fig
design
allow
use
nucleic
acid
deriv
sar
coronaviru
posit
control
viral
rna
cell
infect
sar
coronaviru
dna
plasmid
contain
target
sequenc
posit
assay
expect
use
viral
rna
extract
viru
cultur
known
titer
assay
dynam
rang
least
seven
order
magnitud
x
tcid
reaction
data
shown
accur
determin
detect
limit
assay
also
test
serial
dilut
posit
control
plasmid
assay
preliminari
trial
reaction
copi
posit
control
plasmid
consist
posit
assay
n
dna
amplif
newli
establish
assay
found
effici
amplif
effici
n
gene
assay
respect
fig
r
case
neg
control
found
neg
assay
data
shown
addit
also
spike
known
amount
sar
coronaviru
repres
neg
control
sampl
serial
dilut
viru
sampl
rang
x
tcid
reaction
number
test
per
concentr
rna
extract
spike
sampl
posit
test
signific
rtpcr
inhibit
detect
respiratori
specimen
two
suspect
patient
test
rtpcr
assay
patient
posit
test
tabl
preliminari
result
serial
dilut
rna
sampl
suggest
n
gene
assay
time
sensit
gene
assay
detect
posit
clinic
specimen
sampl
could
test
qualit
assay
test
site
exact
viral
copi
number
specimen
determin
studi
two
assay
target
virus
subgenu
sarbecoviru
made
evalu
intent
made
assay
reactiv
multipl
virus
subgenu
insuffici
public
inform
genet
divers
human
anim
sar
coronavirus
found
palm
civet
human
genet
highli
similar
distinct
exampl
partial
delet
detect
sar
coronaviru
found
palm
civet
similar
subtl
sequenc
variat
also
observ
mer
coronaviru
found
camel
human
avoid
possibl
scenario
genet
divers
much
divers
appreci
primer
probe
set
design
react
clade
coronavirus
evalu
assay
use
panel
posit
neg
control
sampl
assay
found
sensit
specif
sarbecovirus
use
respiratori
specimen
patient
infect
demonstr
potenti
use
test
test
clinic
sampl
differ
natur
sputum
vs
throat
swab
collect
differ
onset
time
day
vs
day
thu
prematur
use
data
determin
viral
replic
kinet
human
systemat
investig
clinic
specimen
collect
patient
differ
postonset
time
point
need
nonetheless
result
demonstr
clinic
valu
respiratori
sampl
molecular
detect
addit
n
gene
rtpcr
assay
found
sensit
detect
rna
studi
clinic
sampl
possibl
clinic
sampl
might
contain
infect
cell
express
subgenom
mrna
result
n
gene
copi
sampl
except
sar
coronaviru
none
sarbecovirus
previous
detect
human
sar
elimin
human
last
report
human
sar
case
detect
individu
sampl
posit
rtpcr
assay
consid
infect
relat
anim
coronavirus
base
detect
perform
n
gene
rtpcr
recommend
screen
assay
assay
recommend
confirmatori
one
use
diagnost
algorithm
similar
mer
n
gene
neg
result
regard
indetermin
case
recommend
refer
refer
lab
test
event
posit
pcr
result
sequenc
analys
posit
amplicon
help
confirm
result
distinguish
genet
relat
coronavirus
eg
sar
coronaviru
biosafeti
classif
yet
fulli
defin
clinic
sampl
molecular
test
detect
recommend
handl
use
biosafeti
level
practic
sar
coronaviru
classifi
biosafeti
level
pathogen
therefor
intent
use
dna
plasmid
posit
control
test
avoid
distribut
sar
coronaviru
genom
rna
potenti
gener
infecti
clone
via
revers
genet
addit
also
help
distribut
posit
control
laboratori
differ
geograph
region
costeffect
robust
manner
dna
plasmid
control
avail
upon
request
review
process
manuscript
corman
colleagu
report
use
synthet
construct
sar
viru
develop
rtpcr
assay
detect
nonstandard
abbrevi
tcid
median
tissu
cultur
infecti
dose
sar
sever
acut
respiratori
syndrom
mer
middl
east
respiratori
syndrom
disclosur
author
contribut
author
confirm
contribut
intellectu
content
paper
met
follow
requir
signific
contribut
concept
design
acquisit
data
analysi
interpret
data
b
draft
revis
articl
intellectu
content
c
final
approv
publish
articl
agreement
account
aspect
articl
thu
ensur
question
relat
accuraci
integr
part
articl
appropri
investig
resolv
k
hui
provis
studi
materi
patient
l
poon
financi
support
provis
studi
materi
patient
